Rapport Therapeutics Stock (NASDAQ: RAPP) stock price, news, charts, stock research, profile.
You can purchase shares of Rapport Therapeutics (NASDAQ:RAPP) through any online brokerage.
Other companies in Rapport Therapeutics’s space includes: Third Harmonic Bio (NASDAQ:THRD), Theravance Biopharma (NASDAQ:TBPH), Zevra Therapeutics (NASDAQ:ZVRA), SNDL (NASDAQ:SNDL) and Xeris Biopharma Holdings (NASDAQ:XERS).
Rapport Therapeutics has a consensus price target of $37.33.
The stock price for Rapport Therapeutics (NASDAQ: RAPP) is $17.9 last updated December 20, 2024 at 4:02 PM EST.
There are no upcoming dividends for Rapport Therapeutics.
Rapport Therapeutics’s Q4 earnings are confirmed for Monday, February 10, 2025.
There is no upcoming split for Rapport Therapeutics.
Rapport Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.